Relevance: GS2 - Government Policies & Interventions; GS3 - Environment and Conservation
(Source: The Hindu, 07/26/2023)
Click here for Daily Current Affairs
Why in the news?
- Recently, the Biological Diversity (Amendment) Bill, 2021 was passed in the Lok Sabha, aiming to amend the existing Biological Diversity Act, 2002.
- The act was initially introduced with the objective of ensuring sustainable and equitable sharing of benefits arising from the utilization of biological resources and traditional knowledge.
- However, over the years, various stakeholders, including traditional medicine practitioners, the seed sector, industry, and researchers, raised concerns about the compliance burden and restrictions hindering research and investments.
![Biological Diversity Amendment Bill Passed In Lok Sabha]()
Key Provisions of the Biological Diversity (Amendment) Bill, 2021
- Exemption for AYUSH Medical Practitioners: The bill seeks to allow AYUSH practitioners to use certain natural resources for the treatments without having to go through extra paperwork or approval processes with biodiversity boards.
- Approval of Intellectual Property Right (IPR): For Intellectual Property Rights (IPR) related to Indian biological resources, National Biodiversity Authority approval is needed before the grant of IPR, not just before application.
- Benefit Sharing: The users of codified traditional knowledge and AYUSH practitioners will be relieved from the obligation of sharing benefits with local communities. It excludes the obligation to share the benefits from research and bio-surveys.
- Offenses and Penalties: The Bill decriminalizes all offenses previously stipulated under the Act, bringing about a significant change in the legal aspect and substitutes them with monetary penalties.
What are the concerns raised?
- Environmentalist organizations such as Legal Initiative for Forests and Environment (LIFE) state that the amendment seems to be done with the sole intention of providing benefit to the Ayush industry.
- The term codified traditional knowledge is not clearly defined.
- The Bill takes away the involvement of local communities in deciding how benefits should be shared.
- Under the Bill, offenses previously considered illegal would no longer be treated as crimes but would carry various penalties.
- The Bill changes the adjudicating authority from a Judge to a government official. The penalty decisions will be based on an inquiry instead of a judgement after arguments in an open court.
About Biological Diversity Act, 2002
- It is a law passed by the Indian Parliament to protect biological diversity and to provide a system for the fair distribution of the advantages brought about by the utilization of traditional biological resources and knowledge.
- To fulfill requirements under the Convention on Biological Diversity (CBD), the Act was passed. This law is necessary to safeguard India's biological legacy because it is one of the most biologically varied countries in the world.
- It was framed to give effect to the United Nations Convention on Biological Diversity (CBD), 1992, that strives for sustainable, fair and equitable sharing of benefits arising out of the utilization of biological resources and associated traditional knowledge.
- The act envisaged a three-tier structure to regulate the access to biological resources:
- The National Biodiversity Authority (NBA)
- The State Biodiversity Boards (SBBs)
- The Biodiversity Management Committees (BMCs)
|
(*Click this link to read prelims specific weekly current affairs articles)
FAQs
Question: What is Biodiversity?
Answer:
The term "biodiversity" refers to the diversity of all types of living things, including those within and between species, as well as the ecological systems of which they are a part.
Question: What is meant by biological resources?
Answer:
The term "biological resources" refers to any plants, animals, or microorganisms, or portions thereof, as well as their genetic material and byproducts (excluding value-added goods), with the exception of human genetic material.
Question: What is the National Biodiversity Authority?
Answer:
The Central Government of India formed the National Biodiversity Authority (NBA) in 2003 to carry out the Biological Diversity Act (2002). It is a statutory organisation that serves the Indian government in a facilitative, regulatory, and advising capacity regarding the preservation and wise use of biological resources.
MCQ
Question: How does the National Biodiversity Authority (NBA) help in protecting Indian agriculture? (UPSC 2012)
- NBA checks the biopiracy and protects the indigenous and traditional genetic resources.
- NBA directly monitors and supervises the scientific research on genetic modification of crop plants.
- Application for intellectual Property Rights related to genetic / biological resources cannot be made without the approval of the NBA.
Which of the statements given above is/are correct?
(a) 1 only
(b) 2 and 3 only
(c) 1 and 3 only
(d) 1, 2 and 3
Answer: (c) See the Explanation
- The National Biodiversity Authority (NBA) monitors biopiracy and safeguards traditional and indigenous genetic resources. Hence, statement 1 is correct.
- A legally independent entity under the Ministry of Environment, the National Biodiversity Authority was created in 2003 to carry out the directives of the National Biological Diversity Act, which was passed in 2002.
- It serves as a facilitator, regulator, and advisory body for the Indian government on matters pertaining to biological resource conservation and sustainable usage.
- Section 6(1) provides that prior approval of NBA is necessary before applying for any kind of IPRs in India and outside based on any research or information on a biological resource obtained from India. Hence, statement 3 is correct.
- The "Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms/Genetically Engineering Organisms or Cells, 1989" were notified under the Environment (Protection) Act, 1986, and established the Genetic Engineering Appraisal Committee (GEAC), a legislative authority.
- The body also considers proposals for the import or production of recombinant pharmaceutical goods that involve live modified organisms that fall under risk categories III and up, or for recombinant pharmaceutical products where the final result is a modified living creature. Hence, statement 2 is incorrect.
Therefore, option (c) is the correct answer.
Comments